You have 9 free searches left this month | for more free features.

City

Boston (2)

Dallas (1)

Nashville (1)

New York (1)

Condition

Esophageal Cancer (2)

Stomach Cancer (2)

Gastric Cancer (1)

Major Depressive Disorder (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

n/a (1)

Sponsor

Dana-Farber Cancer Institute (2)

New York State Psychiatric Institute (1)

Collaborator

Genentech, Inc. (2)

Massachusetts General Hospital (2)

Brigham and Women's Hospital (1)

National Institute of Mental Health (NIMH) (1)

SCRI Development Innovations, LLC (1)

Texas Oncology Cancer Center (1)

Intervention

bevacizumab (2)

cisplatin (2)

docetaxel (2)

irinotecan (2)

cognitive behavior therapy (cbt) (1)

nonspecific supportive therapy (pbo) (1)

Study Documents

Intervention Type

drug (2)

behavioral (1)

device (1)

Funder Type

Other (3)

Study Type

Interventional (3)

TPCA

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Esophageal Cancer, Gastric Cancer, Stomach Cancer Trial in Boston, Nashville, Dallas (Bevacizumab, Cisplatin, Irinotecan)

Active, not recruiting

Has Results

Esophageal Cancer
+2 more

Bevacizumab
+3 more

Boston, Massachusetts
+3 more

Jul 7, 2021

MDD Trial in New York (Cognitive Behavior Therapy (CBT), Nonspecific Supportive Therapy (PBO))

Recruiting

Major Depressive Disorder

Cognitive Behavior Therapy (CBT)
Nonspecific Supportive Therapy (PBO)

New York, New York

New York State Psychiatric Institute

Jun 22, 2022

Esophageal Cancer, Stomach Cancer Trial in Boston (Bevacizumab, Docetaxel, Cisplatin)

Completed

Has Results

Esophageal Cancer
Stomach Cancer

Bevacizumab
+3 more

Boston, Massachusetts
+2 more

Jul 5, 2017